GoodBudz
9 months ago
You would think the recent RS would have been justified by some bold actions by the company.
NOPE.
It was done to enrich the new “management team” and wipe out retail investors. The new mushroom-centric idiots are not aligned with my values. They are obviously out to take money. After a few years of sitting on this, I’m out!
Dr. Barnhill, dumbass Jr., and the entire management team should lay off the psychedelics. But hey, what do they care? As long as their salaries are paid, right?
And Curt is lost if he thinks teaming up with these knuckle heads was a good move. Bunch of hosers IMHO. Hemp has much more legitimate advocates that will hopefully move the industry forward. Regardless of my significant losses with these idiots, I still believe in the future of hemp in the USA!!!🇺🇸
GoodBudz
11 months ago
Yes, I confirmed that a couple of weeks ago. We were slaughtered here at GBHPF.
And now my portfolio finally shows it. Looks like I can trade it again, but my shares are worthless☹️ and who in the right mind would want to buy this anymore?
They’ve proven that they can’t be trusted, and all of their loan interest rates have increased exponentially. Toxic debt spiral. I think I calculated that this needs to get to 8 dollars a share for me to break even lol. That’s not gonna happen.
I truly believe in hemp and its future, but investing in Global Hemp Group was a mistake. Oh well lots of financial scams down here in the sewer, can’t trust any of these CEO’s!
GoodBudz
1 year ago
According to iHub, this thing is trading, but I cannot buy or sell shares. I think I understand what’s happening with the company, but this is the first time I’ve experienced it myself. I hate RS’s, and I’ve never seen one benefit shareholders.
All I do know for certain is this is the second lengthy amount of time this year I am not able to trade this ticker. And I just noticed that OTC Markets has GBHPF listed as a shell risk. So much for my optimism with the stellar new management group and relationship with Apollon. If you visit the GBHPF website, it seems like these guys really have their act together. Something smells skunky here, and I don’t think it’s the good stuff😎
GUNSMOKE
2 years ago
Global Hemp Group Concludes First U.S. Sublicense Related to Its Recently Acquired Exclusive North American License of Apollon Formularies IP
Press Release | 04/28/2023
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that the Company has executed the first North American sublicense for sales and revenue generation in the United States, relating to the recently acquired exclusive license to Apollon Formularies plc's ("Apollon") patents and IP.
Global Hemp Group, Inc. issued a Non-Exclusive Sublicense to Medicinal One, LLC, a Florida corporation, specifically for online eCommerce sales of the Apollon Branded products including both functional mushroom and hemp-based products. This will include Apollon's unique patent protected mushroom/hemp-based combination product line.
Under the terms of the agreement, Medicinal One will pay an in-kind up-front payment that will cover the costs of creating and hosting the eCommerce website, manufacturing the products, promoting the products through various targeted social media ad campaigns, product order fulfilment and direct shipping. In exchange for this non-exclusive sublicense, Medicinal One will pay GHG a 20% gross revenue royalty on all sales monthly. This represents a significant opportunity for GHG to generate revenue in the online eCommerce market throughout the United States where functional mushroom and hemp-based products are legal.
According to Zion Market Research, the global functional mushroom market size was evaluated at $15.3 Billion in 2022 and is slated to hit $23.3 Billion by the end of 2030 with a CAGR of nearly 10.1% between 2023 and 2030…. North America is anticipated to lead the global functional mushroom market growth over the projected timeline due to a surge in the intake of mushrooms as superfoods¹.
The manufacturer that the Company is working with to supply these products has a long history in developing and supplying hemp-based products to the market and has recently expanded into functional mushroom formulations, making them the ideal manufacturer for this project. In addition, the Company has been in discussions with this manufacturer to partner with the Company to manufacture and distribute additional Apollon products not currently covered under this non-exclusive sublicensing agreement.
"We are excited about the opportunity to work with Medicinal One, and we believe that this partnership will be beneficial for both companies," said Stephen Barnhill, Jr, President and CEO of Global Hemp Group, Inc. "This agreement provides GHG with a platform to reach a much wider audience and generate revenue through the online sales of our Apollon branded products. We look forward to working with Medicinal One to maximize the potential of this partnership."
Scott Markowitz, CEO of Medicinal One stated, "We are thrilled to introduce and sell the Apollon functional mushroom and hemp-based products, as well as the functional mushroom/hemp-based combination product line through our online eCommerce platform for sales and shipping throughout the United States where these products are legally allowed. The eCommerce sector has observed a significant rise in popularity as the number of people using mobile phones has increased globally in the last few years simplifying the process of online sales."
The company also wishes to address numerous shareholders inquiries regarding the consolidation of the common shares of the Company and the expiration of the warrants trading on the CSE under the symbol GHG.WT. With respect to share consolidation, GHG has no immediate plans for a share consolidation for the foreseeable future. With respect to the expiry date of the warrants, per the CSE Policy 6.7(3)(a), terms of listed warrants cannot be amended, therefore the expiry date for this group of warrants will remain September 8, 2023.
References:
¹ https://www.zionmarketresearch.com/news/global-functional-mushroom-market
About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) is focused on developing and promoting hemp-based products that are sustainable, environmentally friendly, and have a positive impact on society. To further support and innovate, GHG has established a R&D Division to actively pursue the development of Intellectual Property that can be patented for implementation at its projects and beyond. The Division is led by Prof. Víctor M. Castaño, Ph.D. whose career has focused in the areas of applied science and technology. The R&D team is initially focused on development of Environmentally Friendly Construction Materials, Nanofertilizers and Enhanced Cannabinoid Extraction from Hemp.
For Further Information Contact Global Hemp Group
Investor Relations
Tel: 778-726-2900
info@globalhempgroup.com
www.globalhempgroup.com
GUNSMOKE
2 years ago
Global Hemp Group Announces Brokered Private Placement
Press Release | 04/21/2023
April 21, 2023
OTC Disclosure & News Service
Vancouver, BC, Canada —
This release includes additional documents. Select the link(s) below to view.
2023 Apr 20 - LIFE Offering - Brokered Private Placement.pdf
Vancouver, BC -- (April 20, 2023) -- GLOBAL HEMP GROUP INC. ("GHG" or the "Company") (CSE: GHG / OTC Markets: GBHPF / FRANKFURT: GHG) announces that it will be proceeding with a brokered private placement consisting of the sale of up to 100,000,000 units at $0.01 each (the "Units") for gross proceeds of up to $1,000,000 (the "Offering"). This Offering is being led by EMD Financial Inc., acting as sole bookrunner and replaces the non-brokered private placement announced on March 8, 2023.
Each Unit will consist of one common share (the "Common Shares") and one common share purchase warrant (the "Warrants"). Each Warrant will entitle the holder thereof to acquire an additional Common Share in the capital of the Company at an exercise price of $0.05 for a period of thirty-six (36) months from the date of closing of the private placement.
The proceeds of this private placement will be used for general working capital purposes.
In connection with the Offering, the Company will pay finders fees and issue finder warrants to EMD Financial Inc. as well as any other registrants participating in the Offering consisting of: (i) cash fees of up to 8% of the gross proceeds of the Offering (the Finders Fee); and (ii) finder warrants in an amount equal to up to 8% of the number of Units issued pursuant to the Offering, exercisable at a price of $0.05 per Common Share for a period of twenty-four (24) months following the Closing Date (the Finders Warrants).
The Corporation reserves the right to proceed with multiple closings of the Offering, without any restrictions as to minimum amounts subscribed, on or before May 20, 2023 or such other date not exceeding 45 days from the date hereof as determined by the Company, and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals including the approval of the Canadian Securities Exchange and the securities regulatory authorities.
Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 Prospectus Exemptions (NI 45-106), the Units will be offered for sale to purchasers resident in Canada, and other qualifying jurisdictions pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the Listed Issuer Financing Exemption). Because the private placement is being completed pursuant to the Listed Issuer Financing Exemption, the securities issued in the private placement will not be subject to a hold period pursuant to applicable Canadian Securities laws.
There is an offering document related to this offering that can be accessed under GHGs profile at www.sedar.com and at https://www.globalhempgroup.com/. Prospective investors should read this offering document before making an investment decision.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States or any other jurisdiction. No securities may be offered or sold in the United States or in any other jurisdiction in which such offer or sale would be unlawful absent registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom or qualification under the securities laws of such other jurisdiction or an exemption therefrom.
About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) is focused on developing and promoting hemp-based products that are sustainable, environmentally friendly, and have a positive impact on society. To further support and innovate, GHG has established a R&D Division to actively pursue the development of Intellectual Property that can be patented for implementation at its projects and beyond. The Division is led by Prof. Vctor M. Castao, Ph.D. whose career has focused in the areas of applied science and technology. The R&D team is initially focused on development of Environmentally Friendly Construction Materials, Nanofertilizers and Enhanced Cannabinoid Extraction from Hemp.
Subscribe to the GHG YouTube Channel:
https://www.youtube.com/channel/UCtjFn9dOyHMxJee-_37MTrw
Like us on Facebook: https://www.facebook.com/globalhempgrp
Follow us on Instagram: https://www.instagram.com/hemp_global/
Follow us on Twitter: https://twitter.com/Hemp_Global
Connect with us on LinkedIn: https://www.linkedin.com/company/18596421
For Further Information Contact Global Hemp Group
Investor Relations
Tel: 778-726-2900
info@globalhempgroup.com
www.globalhempgroup.com
retired early
2 years ago
OK maybe Curt has been doing OK for us. Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that further to the Company's announcement of January 11, 2023 regarding the execution of the binding LOI with Apollon Formularies Plc - (AQSE: APOL) ("Apollon"), the Parties have now executed an exclusive licensing agreement (the "License Agreement") dated January 19, 2023 covering the licensing of the right to Apollon's Patent Applications and the Technology for the United States, Canada, and Mexico.
:)
GoodBudz
2 years ago
"GLOBAL HEMP GROUP PROVIDES UPDATE
Vancouver, BC -- (January 4, 2023) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) Further to the Company’s news announcement of January 3, 2023, the Company wishes to provide the following update.
GHG has been focused on executing a multi-phased strategy in the industrial hemp industry. The current phase of this strategy has focused on the opportunity to develop “sustainable” and “green” value-added industrial hemp products utilizing the processing of the entirety of the hemp plant for multi-merchantable applications, which the Company anticipates being showcased at the Colorado Hemp Agro-Industrial Zone (HAIZ) project.
The R&D Division in Querétaro Mexico continues to be an important component of Company’s business model. The R&D team is currently focused on development of patented technology (“IP") that can be widely marketed.
The group is completing work on two initial patents that it expects to file in the first quarter of the year. The first, a novel building material utilizing hemp fibre that has been chemically modified to increase its mechanical performance and then combined with rice husks, an important agricultural by-product found worldwide, creating a product that could be used as a replacement for Medium-Density Fibreboard (MDF) in construction. As rice husks are not biodegradable, this is an ideal method for utilizing the waste from the rice industry. The second patent is an environmentally friendly procedure to extract CDB and other cannabinoids from hemp utilizing enzymes from natural products. The process has proven to be economical, while leaving no residual chemicals or solvents.
The R&D group is also actively exploring additional academic and economic partnerships to expand its research endeavours relating to hemp and hemp-based products.
In addition, the Company is aggressively pursuing new partnership opportunities with natural biologic drug development companies that are developing therapeutic solutions through full spectrum high THC cannabis, functional and psychedelic mushroom formulations in order to diversify and expand the scope of the Company’s operations. The Company expects to be able to update its shareholders on these endeavours in the very near future.
The CSE has confirmed trading in the shares of GHG will resume on Thursday, January 5, 2022"
...Back in the hemp game. Right where I intended to invest;) I like this update. GBHPF in '23 GLTA.
GoodBudz
2 years ago
I'm not certain how this all goes down with a reverse merger/takeover.
Reading the last update I can find indicates today's date has some significance. Unless they decide to extend the DD time and closing of the Definitive Agreement and underlying transactions. Perhaps more updates this week?
What does it mean they will close the contemplated listing on the CSE no later than March 31, 2023? Will the company be private and no longer trade on an exchange? I'd love to know more about the details for the shares owned prior to trade halting.
"GLOBAL HEMP GROUP ANNOUNCES UPDATE ON THE REVITALIZE EARTH REVERSE-TAKEOVER TRANSACTION
Vancouver, BC -- (September 21, 2022) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) Further to the GHG’s news announcements of July 12, 2022 and July 13, 2022, the Company wishes to provide further information on the Revitalize Earth reverse-takeover transaction.
The parties have recently amended their binding Letter of Intent, originally executed on July 8, 2022, to extend the Due Diligence period to October 31, 2022 and to extend the closing of the Definitive Agreement and underlying transactions to October 31, 2022, or any other date that the parties may agree to in writing and in any event, to close the contemplated listing on the CSE no later than March 31, 2023. The parties will endeavor to work to close the listing as expeditiously as possible. In addition to the parties completing their Due Diligence and Definitive Agreement, they are working towards completion of a Listing Statement and Information Circular required for the transaction. Further, as part of the transaction, Revitalize Earth will be completing an audit of their financial statements. The Company will announce each step as it is completed.
In the meantime, trading of GHG Common Shares will remain halted until the Company receives shareholder approval by way of written consent or when the information circular is posted on SEDAR in contemplation of the meeting of shareholders of the Company, whichever route the Company decides to take to that effect."
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Renee
1 year ago
theSauceman
1 year ago
Hot Features
Premium
